Wellspect’s Surity portfolio receives codes
By HME News Staff
Updated 8:46 AM CDT, Thu October 8, 2026
MOLNDAL, Sweden – Wellspect HealthCare has announced that the Surity portfolio, including the Surity Urinary Management System and Surity Female and Male External Catheters, may be covered by traditional Medicare for eligible beneficiaries when medically necessary. The company says this milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S. “Medicare reimbursement for the Surity portfolio represents a significant milestone in our efforts to help individuals living with permanent urinary incontinence benefit from modern solutions that can support their day-to-day needs,” said Chris Schlenk, group vice president at Wellspect HealthCare. “For eligible beneficiaries with permanent urinary incontinence, newly established Medicare coding may help reduce barriers to care and expand choice in urinary management. This achievement reflects our ongoing commitment to helping individuals and their caregivers in managing important care needs with solutions designed to support comfort, confidence, and independence.” The Surity portfolio provides non-invasive management solutions for individuals living with urinary incontinence and is designed to make every day urine management more comfortable, discreet and reliable. Coding verification under Healthcare Common Procedure Coding System (HCPCS) codes is A6590 for the Surity Female and Male External Catheters and E2001 for the Surity Urinary Management System.
Comments